ONK Therapeutics Appoints Hugh O’Dowd as Independent Chairman

Business Wire

Published

GALWAY, Ireland & SAN DIEGO--(BUSINESS WIRE)-- #cancer--ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has appointed Hugh O’Dowd as Director and independent Non-executive Chairman of its Board of Directors. US-based Mr. O’Dowd brings significant experience and a background in the life sciences industry to the ONK Therapeutics’ Board in particular building organizations and commercialization of oncology therapeutics. His experience and strategic insig

Full Article